fda tirzepatide compound update is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA Announces End To Compounded

Peptides like BPC-157, Tesamorelin, and IGF-1 enhance muscle recovery, tissue repair, and fat metabolism, helping individuals retain muscle mass and burn fat more efficiently

Sleep disturbances , anxiety , muscle pain , and joint pain appear in user reports but are not consistently identified in controlled trials as occurring above placebo rates

[17] [18] Supply constraints have affected NHS availability

The honest answer is that the strongest human finding is almost the reverse of what people hope: exercise raises your own MOTS-c, with one study seeing skeletal-muscle levels jump about 12-fold after a workout